Curren & Co. is still a "Buy" (available for free on LaserBond's website) but the price target has fallen from $1.35 to $1.25 (a bit over 100% supposed upside). They reference taking a more conservative approach to growth assumptions in their models in this note, and have put no weight on sales of laser cladding work at Gateway WA.
Some good points made on this forum which could only be described as negative to LBL. I can't disagree with any of it. All very valid and genuine points. I like the comment about how maybe Gateway should have bought LaserBond, rather than the other way around!!
I made a small purchase today at < 60 cents to increase my holding by 25%. No heroics. If it falls another 10% I will likely grab another 25%. The price has fallen for a reason, and there is risk involved. But I can see more revenue growth coming through and these lower price levels are obviously less risky than buying at 12 month highs. We shall see!
- Forums
- ASX - By Stock
- LBL
- Ann: Update - Dividend/Distribution - LBL
LBL
laserbond limited
Add to My Watchlist
0.00%
!
36.0¢

Ann: Update - Dividend/Distribution - LBL, page-58
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.35M |
Open | High | Low | Value | Volume |
36.0¢ | 36.5¢ | 36.0¢ | $219.3K | 608.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49047 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 18685 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49047 | 0.360 |
5 | 79787 | 0.355 |
2 | 10132 | 0.350 |
2 | 30030 | 0.345 |
6 | 21741 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 18685 | 2 |
0.370 | 11746 | 2 |
0.380 | 75000 | 2 |
0.385 | 60000 | 2 |
0.390 | 43000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
LBL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online